KARD

$CGEM $KARD $NRIX shoulda just bought all three lol

$KARD Keith Bryon Johnson (10%+) purchased 3,125,000 shares at an average price of $16.00 (Form 4).

$KARD $CGEM $NRIX going to do some dd in these. Posting to keep on the radar

Kardigan a clinical-stage cardiovascular biotechnology company, has completed its initial public offering, selling 28.75M common shares at $16.00 per share and raising approximately $460M in gross proceeds before underwriting discounts, commissions, and other expenses. The total offering size includes the full exercise of the underwriters’ option to purchase an additional 3.75M shares, indicating solid demand during the book-building process. All shares in the offering were sold directly by the company, meaning proceeds will primarily support corporate funding needs rather than existing shareholders. Following the IPO, KARD began trading on the Nasdaq Global Market under the ticker “KARD.” The company is focused on developing novel cardiovascular therapies targeting diseases with no currently approved treatments, positioning itself in a high-need but highly competitive biotech segment. $KARD

$NEOV $KARD $FCEL $HQ $ATPC well HQ got 45 wow

JUCE is now long on $SUGP @ $1.01 $KARD $MVLL

JUCE added a long on $MVLL @ $194.98 $KARD

$NEOV tested 3 and we want 2.65 to hold on a dip for break of 3 to 3.50/4 $KARD new issue ran to 23.75, ending at 22. If 20 holds it can move to 23 and 25 $FCEL had a strong day to 24.36, has 23 support and it can get 25 to 28 $HQ we want 28 to hold for a move back to 30 and 33 $ATPC see if 4 holds with volume to 5 and 6.15

Top Gainers PT2 $APWC $ATPC $BESS $KARD $HQ

$BESS $KARD $HQ $NEOV $EXFY "The critical ingredient is getting off your butt and doing something. It's as simple as that. A lot of people have ideas, but there are few who decide to do something about them now. Not tomorrow. Not next week. But today." Nolan Bushnell

Top Gainers PT2 $APWC $ATPC $BESS $KARD $HQ